Laser research: Kidney, abstracts and studies


Photomedicine and Laser Surgery Volume 30, Number 12, 2012

Low-Level Laser Therapy Decreases Renal Interstitial Fibrosis

Fabiana Aparecida Mayrink Oliveira, M.D.,1,2 Ana Carolina Meneghin Moraes, M.D.,1,2 Amanda Povoa Paiva, M.D.,1,2 Vaˆ nia Schinzel, M.D.,1,2 Matheus Correa-Costa, Ph.D.,3,4 Patricia Semedo, Ph.D.,4 Angeˆ la Castoldi, B.S., M.Sc.,4 Marcos Antonio Cenedeze,4 Roberto Sotto-Maior Fortes Oliveira, Ph.D.,2 Marcus Gomes Bastos, M.D., Ph.D.,1 Niels Olsen Saraiva Caˆ mara, M.D., Ph.D.,3,4 and Helady Sanders-Pinheiro, M.D., Ph.D.1–4

Objective: The purpose of this study was to investigate the effect of low-level laser therapy (LLLT) on chronic kidney disease (CKD) in a model of unilateral ureteral obstruction (UUO).

Background Data:Regardless of the etiology, CKD involves progressive widespread tissue fibrosis, tubular atrophy, and loss of kidney function. This process also occurs in kidney allograft. At present, effective therapies for this condition are lacking. We investigated the effects of LLLT on the interstitial fibrosis that occurs after experimental UUO in rats.

Methods: The occluded kidney of half of the 32 Wistar rats that underwent UUO received a single intraoperative dose of LLLT (AlGaAs laser, 780 nm, 22.5 J/cm2, 30mW, 0.75W/cm2, 30 sec on each of nine points). After 14 days, renal fibrosis was assessed by Sirius red staining under polarized light. Immunohistochemical analyses quantitated the renal tissue cells that expressed fibroblast (FSP-1) and myofibroblast (a-SMA) markers. Reverse transcriptase polymerase chain reaction (RT-PCR) was performed to determine the mRNA expression of interleukin (IL)-6, monocyte chemotactic protein-1 (MCP-1), transforming growth factor (TGF)-b1 and Smad3.

Results: The UUO and LLLT animals had less fibrosis than the UUO animals, as well having decreased expression inflammatory and pro-fibrotic markers.

Conclusion: For the first time, we showed that LLLT had a protective effect regarding renal interstitial fibrosis. It is conceivable that by attenuating inflammation, LLLT can prevent tubular activation and transdifferentiation, which are the two processes that mainly drive the renal fibrosis of the UUO model.

Hinweis: Die Lasertherapie (LLLT) ist in Deutschland wissenschaftlich noch nicht anerkannt und gehört zu den komplementären Therapieverfahren.